2021 Annual Meeting Biologics Access Pass-The Use of Autogenous Tissue as OrthoBiologic Therapy: What Are the Options and Do they Really Work?

The Use of Autogenous Tissue as OrthoBiologic Therapy: What Are the Options and Do they Really Work?

Video Transcription

Video Summary

The speaker discusses autogenous cellular therapies, focusing on regulatory FDA guidelines and current options like PRP and adipose tissue. PRP, effective for tendinopathies and early osteoarthritis (OA), is safe and cost-effective. Adipose tissue therapy, favored for its higher activated cell count and stability across ages, shows promise for knee and shoulder OA and soft tissue healing. Studies indicate safety and pain relief, with emerging evidence supporting durability of benefits. Despite limited high-level evidence and FDA scrutiny intensifying, ongoing research and new trials with true mesenchymal stem cells (MSCs) are encouraging. The speaker urges caution respecting regulations but remains optimistic about future advancements.

Asset Caption

Dr. Claude Moorman

Keywords

autogenous cellular therapies

FDA guidelines

PRP therapy

adipose tissue therapy

mesenchymal stem cells